Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis
使用非人灵长类动物模型来定义 T 细胞免疫反应在持续性卡波西肉瘤相关疱疹病毒感染和卡波西肉瘤发病机制中的作用
基本信息
- 批准号:10667986
- 负责人:
- 金额:$ 34.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS with Kaposi&aposs sarcomaAnimal ExperimentsAnimal ModelAnimalsAntibodiesAntibody ResponseB-LymphocytesBiochemicalBlood PressureCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCallithrixCallithrix jacchus jacchusCancer EtiologyCase StudyCell CountCellsChemicalsCollaborationsComplexDefectDevelopmentDoseDropsDrug KineticsEtiologyExcisionExhibitsFrequenciesHIVHIV SeronegativityHIV/AIDSHerpesviridae InfectionsHumanHuman Herpesvirus 8ImmuneImmune responseImmune systemImmunocompetentImmunocompromised HostImmunologic Deficiency SyndromesImmunosuppressionIn VitroIndividualInfectionIntravenousJapanKaposi SarcomaLaboratoriesLesionLightMalignant NeoplasmsMediatingMethodsModelingMonkeysMonoclonal AntibodiesMusNewly DiagnosedPathogenesisPeripheral Blood Mononuclear CellPersonsPlayPopulationPredispositionPrimatesPropertyReagentResearchResolutionResourcesRoleSerumSplenocyteT cell reconstitutionT cell responseT-Cell DepletionT-LymphocyteTacrolimusToxic effectUreaViral Load resultVirusVirus DiseasesWisconsincell mediated immune responsecytotoxic CD8 T cellsfrontierhigh riskhuman pathogenimmunosuppressedimprovedin vivoin vivo Modelmurine monoclonal antibodynonhuman primateoral infectionpermissivenessreconstitutionrespiratoryresponseside effectskin lesiontool
项目摘要
PROJECT ABSTRACT
Kaposi sarcoma-associated herpesvirus (KSHV) is the causative agent of several human malignancies including
Kaposi sarcoma (KS). KS is the most common KSHV-associated malignancy, with >44,000 new cases reported
worldwide each year. The population most vulnerable to KSHV/KS are immunocompromised individuals such
as people infected with HIV. Individuals with HIV/AIDS have a higher risk of developing KS when compared to
HIV-negative individuals. The adaptive T cell immune response, especially CD4+ and CD8+ T cells, has been
shown to play a crucial role in KSHV infection and subsequent KS pathogenesis. Although correlations between
CD4+ and CD8+ T cell levels and KS development have been observed, this relationship has not been
experimentally validated due to the lack of a suitable animal model. The recent development of the common
marmoset (Callithrix jacchus) as a non-human primate (NHP) model that is susceptible to KSHV infection and
capable of developing KS-like lesions under immunosuppression opens new frontiers to experimentally validate
the role immune cells play in KS development. Thus, our objective is to define the role of reduced CD4+ and
CD8+ T cell levels in persistent KSHV infection and subsequent KS pathogenesis in the marmoset NHP model.
Anti-CD4 and anti-CD8 monoclonal antibodies (mAbs) have been used to deplete T cells and induce
immunosuppression in both murine and NHP animal models, enabling study of CD4+/CD8+ T cells in controlling
replication of several viruses. To avoid any adverse responses to murine mAbs when administered into
marmosets, we will chimerize (murine-marmoset) anti-CD4/CD8 mAbs and characterize their biochemical and
pharmacokinetic properties in vitro and in mice, then we will determine the effects of antibody-mediated T cell
depletion on various immune cell populations (Aim 1). We will then challenge immunosuppressed marmosets
with KSHV.219 virus and determine the extent to which antibody-mediated depletion of CD4+ and/or CD8+ T
cells enables persistent KSHV infection and KS pathogenesis in immunocompromised marmosets (Aim 2). The
successful completion of this project will validate the common marmoset as a tool for understanding the etiology
of KS and uncover the critical role that CD4+ and/or CD8+ T cell depletion plays in allowing persistent KSHV
infection and subsequent KS pathogenesis in immunocompromised animals.
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lorraine Zvichapera Mutsvunguma其他文献
Lorraine Zvichapera Mutsvunguma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
The antitumor effect of histone deacetylase inhibitor against multidrug-resistant Ewing' s sarcoma cells
组蛋白脱乙酰酶抑制剂对多重耐药尤文氏肉瘤细胞的抗肿瘤作用
- 批准号:
21791409 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
NON-HUMAN PRIMATE MODEL OF KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS INFECTION
卡波西肉瘤相关疱疹病毒感染的非人灵长类动物模型
- 批准号:
7715514 - 财政年份:2008
- 资助金额:
$ 34.55万 - 项目类别:
Role of viral microRNAs in Kaposi´s Sarcoma-associated Herpesvirus (KSHV) infection and KSHV-associated Disease
病毒 microRNA 在卡波西肉瘤相关疱疹病毒 (KSHV) 感染和 KSHV 相关疾病中的作用
- 批准号:
37904962 - 财政年份:2007
- 资助金额:
$ 34.55万 - 项目类别:
Research Grants
KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS GENE EXPRESSION
卡波西肉瘤相关疱疹病毒基因表达
- 批准号:
7349564 - 财政年份:2006
- 资助金额:
$ 34.55万 - 项目类别:
KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS K1 SIGNALOSOME
卡波西肉瘤相关疱疹病毒 K1 信号体
- 批准号:
7349565 - 财政年份:2006
- 资助金额:
$ 34.55万 - 项目类别:














{{item.name}}会员




